Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis

Mark Rabinovitch1, Laura Béchard-Evans, Norbert Schmitz

  • 1Assistant Professor, Department of Psychiatry, McGill University, Douglas Hospital Research Centre, Montreal, Quebec.

Insights

Patients with first-episode psychosis (FEP) who have poor social support and family support are less likely to adhere to medication. Early acceptance of medication also predicts adherence in FEP treatment.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Pharmacology

Background:

  • Medication adherence is crucial for managing first-episode psychosis (FEP).
  • Factors influencing adherence in FEP patients require further investigation.
  • Social and family support may play a role in treatment adherence.

Purpose of the Study:

  • To test if poor social and family support at treatment initiation predicts nonadherence in the first 6 months of FEP treatment.
  • To assess the independence of this association from other patient-related factors.

Main Methods:

  • 100 patients with FEP were evaluated monthly for 6 months on medication adherence.
  • Sociodemographic factors, illness characteristics, and social/family support were assessed.
  • Univariate analyses and logistic regression were used to identify predictors of adherence.

Main Results:

  • 54.9% of patients were adherent; 45.1% were nonadherent.
  • Nonadherent patients had lower social support and were more likely to be single.
  • Refusal of medication at the first offer was a strong predictor of nonadherence.

Conclusions:

  • Social and family support are significant factors for early medication adherence in FEP.
  • Early acceptance or rejection of medication strongly influences adherence.
  • Interventions should consider social support and early medication engagement.
Abstract

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...